Arch Venture Corp »

10x Genomics Inc Cl A shares owned by Arch Venture Corp

Quarter-by-quarter ownership of 10x Genomics Inc Cl A (TXG) shares owned by Arch Venture Corp from 13F filings

Historical chart of Arch Venture Corp investment in 10x Genomics Inc Cl A

Tip: Access up to 7 years of quarterly data

All positions including 10x Genomics Inc Cl A held by Arch Venture Corp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 10x Genomics Inc Cl A by Arch Venture Corp

Quarter filed Position value Share count Share price at filing
2025-12-31 $12M 738k 16.31

More positions owned by Arch Venture Corp

Maze Therapeatics (MAZE)
Beam Therapeutics (BEAM)
Rapport Therapeutics (RAPP)
Lyell Immunopharma Com New (LYEL)
Vir Biotechnology (VIR)
Erasca (ERAS)
Gossamer Bio (GOSS)
10x Genomics Cl A Com (TXG)
Q32 Bio (QTTB)

View all positions for Arch Venture Corp

Top funds holding 10x Genomics Inc Cl A

Vanguard Group
ARK Investment Management
BlackRock
FMR
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Millennium Management
Quantinno Capital Management
Wellington Management Company
Goldman Sachs Group
Geode Capital Management
AQR Capital Management
Jacobs Levy Equity Management
State Street Corporation
Renaissance Technologies

View all funds holding 10x Genomics Inc Cl A